All of the following are considered minor considerations when evaluating clinical trials EXCEPT:
Blog
Which of the following are true regarding Medical Subject He…
Which of the following are true regarding Medical Subject Headings (MeSH)? Select all that apply
Limitations of post-marketing surveillance studies include:
Limitations of post-marketing surveillance studies include:
In a study examining the relationship between dosage of Drug…
In a study examining the relationship between dosage of Drug Y and its effect on blood pressure, the regression slope is 0.45. What does this mean?
A study compares the average pain scores among patients usin…
A study compares the average pain scores among patients using three different types of analgesics. Which test should be used to determine if there are significant differences in mean pain scores?
Evaluation of inclusion and exclusion criteria are two of th…
Evaluation of inclusion and exclusion criteria are two of the major considerations when evaluating clinical trials.
A study measures patient adherence before and after a counse…
A study measures patient adherence before and after a counseling intervention. The researchers want a test that considers both the direction and magnitude of change. Which test should they use?
In a trial assessing smoking cessation, caffeine use is asso…
In a trial assessing smoking cessation, caffeine use is associated with both smoking and anxiety—the outcome being studied. This is an example of:
A group of patients with hypertension is monitored before an…
A group of patients with hypertension is monitored before and after a 12-week exercise program. The goal is to determine if their mean systolic blood pressure has significantly decreased. Which test should be used?
In a clinical trial evaluating a new cholesterol-lowering me…
In a clinical trial evaluating a new cholesterol-lowering medication: Treatment group: 18 out of 150 patients experienced a cardiac event Control group: 32 out of 150 patients experienced a cardiac event What is the relative risk of experiencing a cardiac event in the treatment group compared to the control group?